Pages that link to "Q34544847"
Jump to navigation
Jump to search
The following pages link to Potential for immunotherapy in the treatment of herpesvirus infections (Q34544847):
Displaying 8 items.
- A live-attenuated HSV-2 ICP0 virus elicits 10 to 100 times greater protection against genital herpes than a glycoprotein D subunit vaccine (Q21089976) (← links)
- The adjuvant CLDC increases protection of a herpes simplex type 2 glycoprotein D vaccine in guinea pigs (Q33820412) (← links)
- Estradiol regulates susceptibility following primary exposure to genital herpes simplex virus type 2, while progesterone induces inflammation (Q33835479) (← links)
- Of mice and not humans: How reliable are animal models for evaluation of herpes CD8 -T cell-epitopes-based immunotherapeutic vaccine candidates? (Q35173777) (← links)
- Towards an effective genital herpes vaccine: past lessons and future prospects (Q36991575) (← links)
- Induction of therapeutic antibodies by vaccination against external loops of tumor-associated viral latent membrane protein (Q37410691) (← links)
- Comparative efficacy and immunogenicity of replication-defective, recombinant glycoprotein, and DNA vaccines for herpes simplex virus 2 infections in mice and guinea pigs (Q37746861) (← links)
- Eczema herpeticatum (Q44901492) (← links)